Inhibition of ubiquitin-protein ligase (E3) by mono- and bifunctional phenylarsenoxides. Evidence for essential vicinal thiols and a proximal nucleophile.

作者: E.S. Berleth , E.M. Kasperek , S.P. Grill , J.A. Braunscheidel , L.A. Graziani

DOI: 10.1016/S0021-9258(18)42017-0

关键词:

摘要: Trivalent arsenoxides bind to vicinal thiol groups of proteins. We showed previously that the simplest trivalent arsenoxide, inorganic arsenite, inhibits ubiquitin-dependent protein degradation in rabbit reticulocyte lysate (Klemperer, N.S., and Pickart, C.M. (1989) J. Biol. Chem. 264, 19245-19242). now show that, relative phenylarsenoxides are 10-165-fold more potent inhibitors same system (K0.5 for inhibition by p-aminophenylarsenoxide was 3.5-20 microM, depending on substrate). In proteolytic pathway, covalent ligation ubiquitin substrates targets latter degradation. certain cases, specificity ubiquitin-substrate conjugation depends critically upon properties ubiquitin-protein ligase or E3. Among other effects, decreased steady-state level ubiquitinated human alpha-lactalbumin; this is a substrate which acted directly ligase-alpha (E3-alpha). This finding suggests (unlike arsenite) inhibit Several lines evidence confirm conclusion. 1) A complex E3-alpha 14-kDa ubiquitin-conjugating (E2) isozyme binds phenylarsenoxide-Sepharose resin, with E3 component mediating binding. 2) p-Aminophenylarsenoxide inhibited isolated approximately 50 microM); readily reversed addition dithiothreitol (which contains competing group), but not beta-mercaptoethylamine (a monothiol). 3) bifunctional phenylarsenoxide (bromoacetylaminophenylarsenoxide) rapidly irreversibly inactivated E3; bromoacetyl aniline, lacks an arsenoxide moiety, did These results suggest possesses essential there reactive nucleophile proximal site. The should be useful tool probing relationship between structure function As expected from prior also inhibitor turnover ubiquitin-(human) alpha-lactalbumin conjugates.

参考文章(32)
N S Klemperer, C M Pickart, Arsenite inhibits two steps in the ubiquitin-dependent proteolytic pathway Journal of Biological Chemistry. ,vol. 264, pp. 19245- 19252 ,(1989) , 10.1016/S0021-9258(19)47293-1
B. Bartel, I. Wünning, A. Varshavsky, The recognition component of the N-end rule pathway. The EMBO Journal. ,vol. 9, pp. 3179- 3189 ,(1990) , 10.1002/J.1460-2075.1990.TB07516.X
A L Haas, P M Bright, The resolution and characterization of putative ubiquitin carrier protein isozymes from rabbit reticulocytes. Journal of Biological Chemistry. ,vol. 263, pp. 13258- 13267 ,(1988) , 10.1016/S0021-9258(18)37699-3
M Jauhiainen, K J Stevenson, P J Dolphin, Human plasma lecithin-cholesterol acyltransferase. The vicinal nature of cysteine 31 and cysteine 184 in the catalytic site. Journal of Biological Chemistry. ,vol. 263, pp. 6525- 6533 ,(1988) , 10.1016/S0021-9258(18)68673-9
A Hershko, H Heller, S Elias, A Ciechanover, Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. Journal of Biological Chemistry. ,vol. 258, pp. 8206- 8214 ,(1983) , 10.1016/S0021-9258(20)82050-X
C M Pickart, A T Vella, Levels of active ubiquitin carrier proteins decline during erythroid maturation. Journal of Biological Chemistry. ,vol. 263, pp. 12028- 12035 ,(1988) , 10.1016/S0021-9258(18)37888-8
C M Pickart, I A Rose, Functional heterogeneity of ubiquitin carrier proteins. Journal of Biological Chemistry. ,vol. 260, pp. 1573- 1581 ,(1985) , 10.1016/S0021-9258(18)89632-6
H Heller, A Hershko, A ubiquitin-protein ligase specific for type III protein substrates. Journal of Biological Chemistry. ,vol. 265, pp. 6532- 6535 ,(1990) , 10.1016/S0021-9258(19)39177-X